Descriptor English: | Leukotriene A4 | ||||||
Descriptor Spanish: |
Leucotrieno A4
| ||||||
Descriptor Portuguese: | Leucotrieno A4 | ||||||
Descriptor French: | Leucotriène A4 | ||||||
Entry term(s): |
LTA4 Leukotriene A Leukotriene A 4 Leukotriene A-4 Leukotrienes A |
||||||
Tree number(s): |
D10.251.355.255.100.450.405 D10.251.355.310.166.887.405 D23.469.050.175.450.400 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D017572 | ||||||
Scope note: | (2S-(2 alpha,3 beta(1E,3E,5Z,8Z)))-3-(1,3,5,8-Tetradecatetraenyl)oxiranebutanoic acid. An unstable allylic epoxide, formed from the immediate precursor 5-HPETE via the stereospecific removal of a proton at C-10 and dehydration. Its biological actions are determined primarily by its metabolites, i.e., LEUKOTRIENE B4 and cysteinyl-leukotrienes. Alternatively, leukotriene A4 is converted into LEUKOTRIENE C4 by glutathione-S-transferase or into 5,6-di-HETE by the epoxide-hydrolase. (From Dictionary of Prostaglandins and Related Compounds, 1990) |
||||||
Annotation: | /biosyn /physiol permitted |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Previous Indexing: |
Arachidonic Acids (1980-1988) Leukotrienes (1989-1993) |
||||||
Public MeSH Note: | 94; LEUKOTRIENE A was indexed under LEUKOTRIENES 1989-93 & ARACHIDONIC ACIDS 1980-88 |
||||||
Online Note: | use LEUKOTRIENE A4 (NM) to search LEUKOTRIENE A 1980-93 |
||||||
History Note: | 94; was LEUKOTRIENE A (NM) 1980-93 |
||||||
DeCS ID: | 31351 | ||||||
Unique ID: | D017572 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1994/01/01 | ||||||
Date of Entry: | 1993/06/04 | ||||||
Revision Date: | 2015/06/08 |
-
-
CHEMICALS AND DRUGS
Lipids [D10]Lipids -
CHEMICALS AND DRUGS
Lipids [D10]Lipids -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
Leukotriene A4
- Preferred
Leukotriene A
- Broader
Concept UI |
M0026633 |
Scope note | (2S-(2 alpha,3 beta(1E,3E,5Z,8Z)))-3-(1,3,5,8-Tetradecatetraenyl)oxiranebutanoic acid. An unstable allylic epoxide, formed from the immediate precursor 5-HPETE via the stereospecific removal of a proton at C-10 and dehydration. Its biological actions are determined primarily by its metabolites, i.e., LEUKOTRIENE B4 and cysteinyl-leukotrienes. Alternatively, leukotriene A4 is converted into LEUKOTRIENE C4 by glutathione-S-transferase or into 5,6-di-HETE by the epoxide-hydrolase. (From Dictionary of Prostaglandins and Related Compounds, 1990) |
Preferred term | Leukotriene A4 |
Entry term(s) |
LTA4 Leukotriene A 4 Leukotriene A-4 |
Concept UI |
M0026634 |
Preferred term | Leukotriene A |
Entry term(s) |
Leukotrienes A |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey